Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
DexCom logo

DexCom Cash Flow Statement

Operating, investing, and financing cash movements

DexCom generated $1.8B in operating cash flow over the trailing twelve months. After $353.1M in capital expenditures, free cash flow was $1.4B. Free cash flow increased 1.5% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$1.8BNet Cash From Investing (TTM)-$182.1MNet Cash From Financing (TTM)-$1.7BCapital Expenditures (TTM)$353.1MDepreciation And Amortization Cf (TTM)$258.9MNet Change In Cash (TTM)-$255.5M
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$29.0B
P/E Ratio31.21
ROE35.62%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$124.6M$87M$94.1M$80.5M$101.9M$76.6M
Payment for (Proceeds from) Other Investing Activity$16.4M$500K$0-$1M-$100K$0
Payments to Acquire Other Investments$75.1M$0——$1.2M$1.5M
Proceeds From Sale And Maturity Of Available For Sale Securities$405.2M$650.2M$638.7M$466.2M$409.6M$468.2M
Net cash from investing activities-$303.7M$100.2M—$192.8M$306.6M-$298.5M
Other investing activities$16.4M$500K$0-$1M-$100K$0
Proceeds from maturities/sales of investments$405.2M$650.2M$638.7M$466.2M$409.6M$468.2M
Purchases of investments$492.8M$462.5M$608.2M$175.9M$0$688.6M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable$0$125.4M$234M——$145.1M
Change in accounts receivable$7.4M$148.9M$184.6M—$106.2M-$124.6M
Change in accrued liabilities—-$600K$15.9M$41.3M$0-$47.1M
Change in inventories-$32.7M-$6.2M$18.5M$33.6M$17.8M$65.2M
Change in other assets—-$16.5M$22M$2.4M$6.9M-$51M
Change in other liabilities-$7.7M$2.7M-$300K-$7.7M-$6.2M$7.3M
Other working capital changes—$16.5M—$6M$3.1M$0
Deferred income taxes—-$5.8M-$8.9M$118M$78.9M$300K
Depreciation and amortization$57.8M$60M$63M$63.6M$65.2M$67.1M
Net gains (losses) on investments—-$4.2M—$82.7M—$0
Net cash from operating activities$301.4M$183.8M$303M$659.9M$294M$525.6M
Net income$151.7M$105.4M$179.8M$283.8M$267.3M$199.5M
Equity Securities, FV-NI, Gain (Loss)—-$4.2M—$82.7M—$0
Accrued compensation and employee benefits—-$600K$15.9M$41.3M$0-$47.1M
Increase (Decrease) In Operating Lease Assets And Liabilities, Net$3.5M$900K$2.1M$1.5M$2.6M$1.3M
Increase (Decrease) in Prepaid Expense and Other Assets—-$16.5M$22M$2.4M$6.9M-$51M
Other Noncash Income (Expense)—$16.5M—$6M$3.1M$0
Payment-in-kind interest$1.9M$1.9M$1.8M$1.9M$1.7M$1M
Stock-based compensation$43.3M$34.2M$45.3M$45.1M$35M$43.3M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other, net-$1.6M-$1.7M-$1.7M-$1.7M-$1.9M-$1.9M
Repayments For Maturity Of Senior Convertible Notes$0$301.9M$301.9M$301.9M$301.9M—
Net cash from financing activities-$1.6M$12.5M-$1.7M-$175M-$1.5B-$25M
Other financing activities-$1.6M-$1.7M-$1.7M-$1.7M-$1.9M-$1.9M
Proceeds from issuance of common stock—$14.2M—$13.9M—$12.7M
Taxes paid for net share settlement—$0———$35.8M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$176.8M$96.8M$208.9M$579.4M$192.1M$449M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$11.2M$2.3M$16.5M$0$3.8M-$2.8M
Net increase (decrease) in cash—$298.8M$254.2M$676.6M—$199.3M
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1—$57.6M——$16.3M$50.4M
Leased assets obtained in exchange for finance lease liabilities—$1.1M$300K——$2M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$49.5M$23.6M$23.6M$23.6M$23.6M—
Interest paid$2.9M$2.9M$2.9M$2.9M$2.9M—
Right-of-use assets obtained in exchange for operating lease liabilities—$0$500K$2.2M—$400K